Abstract
Objectives
To evaluate how the timing of pedicle screw fixation (early or late) in pyogenic spondylitis relates to the period of hospitalization, duration of intravenous antibiotic use, and recurrence of infection and to confirm the efficacy of early pedicle screw fixation for pyogenic spondylitis.
Summary of Literature Review
Intravenous antibiotics and surgery including debridement and fixation are used as a treatment option for pyogenic spondylitis.
Materials and Methods
We retrospectively reviewed 31 patients who underwent posterior decompression and pedicle screw fixation with intravenous antibiotic treatment for pyogenic spondylitis from November 2005 to February 2015. We divided the study group into an early fixation group, whose instrumentation was inserted no later than 15 days after antibiotic therapy, and a late fixation group for cases who underwent the procedure 15 days or more after antibiotic therapy. We compared the period of hospitalization and intravenous antibiotic treatment, the rate and period of the prescription of oral antibiotics, and the rate of recurrence or reoperation.
Results
The period of hospitalization and intravenous antibiotic treatment of the early fixation group (55 and 43.4 days) were significantly shorter than those of the late fixation group (85 and 67.1 days). The rate and period of the prescription of oral antibiotics were not significantly different between the two groups. There was no case of recurrence or reoperation in either group.
REFERENCES
1. Skaf GS, Domloj NT, Fehlings MG, et al. Pyogenic spondylodiscitis: an overview. J Infect Public Health. 2010; 3:5–16.
2. McHenry MC, Easley KA, Locker GA. Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleve-land-area hospitals. Clin Infect Dis. 2002; 34:1342–50.
3. Hadjipavlou AG, Mader JT, Necessary JT, et al. Hematog-enous pyogenic spinal infections and their surgical management. Spine (Phila Pa 1976). 2000; 25:1668–79.
4. Kuklo TR, Potter BK, Bell RS, et al. Single-stage treatment of pyogenic spinal infection with titanium mesh cages. J Spinal Disord Tech. 2006; 19:376–82.
5. Emery SE, Chan DP, Woodward HR. Treatment of hema-togenous pyogenic vertebral osteomyelitis with anterior debridement and primary bone grafting. Spine (Phila Pa 1976). 1989; 14:284–91.
6. Gasbarrini AL, Bertoldi E, Mazzetti M, et al. Clinical features, diagnostic and therapeutic approaches to haematog-enous vertebral osteomyelitis. Eur Rev Med Pharmacol Sci. 2005; 9:53–66.
7. Fouquet B, Goupille P, Gobert F, et al. Infectious discitis diagnostic contribution of laboratory tests and percutaneous discovertebral biopsy. Rev Rhum Engl Ed. 1996; 63:24–9.
8. Friedman JA, Maher CO, Quast LM, et al. Spontaneous disc space infections in adults. Surg Neurol. 2002; 57:81–6.
9. Lin TY, Tsai TT, Lu ML, et al. Comparison of two-stage open versus percutaneous pedicle screw fixation in treating pyogenic spondylodiscitis. BMC Musculoskelet Disord. 2014; 15:443.
10. Dimar JR, Carreon LY, Glassman SD, et al. Treatment of pyogenic vertebral osteomyelitis with anterior debridement and fusion followed by delayed posterior spinal fusion. Spine (Phila Pa 1976). 2004; 29:326–32.
11. Gonzalvo A, Abdulla I, Riazi A, et al. Single-level/single-stage debridement and posterior instrumented fusion in the treatment of spontaneous pyogenic osteomyelitis/discitis: long-term functional outcome and health-related quality of life. J Spinal Disord Tech. 2011; 24:110–5.
13. Govender S. Spinal infections. J BoneJoint Surg Br. 2005; 87:1454–8.
Table 1.
Demographic variables | Early operation group | Delayed operation group | p-value |
---|---|---|---|
Number of patients | 15 | 16 | |
Age distribution (years) | 61.1 ± 11.7 | 58.6 ±15.4 | 0.617 |
Sex (M:F) | 11:4 | 10:6 | 0.704 |
BMI | 21.9 ± 4.6 | 23.0 ± 3.4 | 0.453 |
Underline disease (#) | |||
Liver cirrhosis | 1 | 0 | 0.484 |
Chronic kidney disease | 2 | 2 | 1.00 |
Diabetic mellitus | 8 | 8 | 1.00 |
Cardiovascular disease | 5 | 8 | 0.475 |
Malignancy | 0 | 1 | 1.00 |
Pathogen (#) | |||
MRSA∗ | 4 | 6 | 0.704 |
MRCNS† | 1 | 0 | 0.484 |
K. pneumoniae‡ | 1 | 2 | 1.00 |
CNS§ | 1 | 1 | 1.00 |
Enterobacter | 1 | 1 | 1.00 |
MSSA | 1 | 0 | 0.484 |
Enterococcus | 1 | 0 | 0.484 |
GBS∥ | 1 | 0 | 0.484 |
P. aeruginosa¶ | 1 | 0 | 0.484 |
Unknown | 3 | 6 | 0.433 |